Portfolio List
Advances in lead discovery with high-throughput sequencing data and in-silico models
View moreA deep learning tool and service for next-generation antibody humanization
Antibody humanization is crucial in developing therapeutic drugs, yet traditional methods often fall short in quality and efficiency. Discover our new deep learning tool and service for next-generation antibody humanization.
View moreSolving big data challenges in therapeutic discovery
High-throughput sequencing and screening are revolutionizing therapeutic discovery. In this presentation, we discuss how data analysis solutions and emerging AI applications can propel your therapeutic discovery with these large new datasets.
View moreSimply select better antibodies with the IGX Platform
Looking to expand and diversify your antibody candidate pool? The IGX Platform provides an intuitive, end-to-end solution engineered to address antibody discovery challenges and streamline candidate selection. Discover how to quickly go from millions of candidate sequences to a final, diverse set of most promising antibody candidates.
View more